Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00118053
Status:
TERMINATED
Last Update Posted:
2013-11-20
First Post:
2005-07-08
Brief Title:
Trastuzumab Docetaxel and Carboplatin in Treating Women With Stage II Stage III or Inflammatory Breast Cancer
Sponsor:
University of Medicine and Dentistry of New Jersey
Organization:
Rutgers The State University of New Jersey
Organization Data
Organization:
Rutgers The State University of New Jersey
Class:
OTHER
Study ID:
040412CDR0000433511
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Aventis Pharmaceuticals | INDUSTRY |
| National Cancer Institute NCI | NIH |